Cas:151166-75-5 3,5-ditert-butyl-4-(methoxymethoxy)benzaldehyde manufacturer & supplier

Chemical Name:3,5-ditert-butyl-4-(methoxymethoxy)benzaldehyde

CAS.NO:151166-75-5

Synonyms:3,5-di-tert-butyl-4-methoxymethyloxybenzaldehyde;3,5-di-tert-butyl-4-methoxymethoxybenzaldehyde;4-Methoxymethoxy-3,5-di-tert-butylbenzaldehyde

Molecular Formula:C₁₇H₂₆O₃

Molecular Weight:278.38700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:35.53000

Exact Mass:278.18800

LogP:4.07680

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,5-di-tert-butyl-4-methoxymethyloxybenzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Methoxymethoxy-3,5-di-tert-butylbenzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-di-tert-butyl-4-methoxymethoxybenzaldehyde Use and application,3,5-di-tert-butyl-4-methoxymethyloxybenzaldehyde technical grade,usp/ep/jp grade.

Related News: Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration. 3,5-ditert-butyl-4-(methoxymethoxy)benzaldehyde manufacturer  The StartScore model was developed by the company��s in-house supply chain experts based on actual performance data. 3,5-ditert-butyl-4-(methoxymethoxy)benzaldehyde supplier After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. 3,5-ditert-butyl-4-(methoxymethoxy)benzaldehyde vendor Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration. 3,5-ditert-butyl-4-(methoxymethoxy)benzaldehyde factory ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.��